These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15806)

  • 1. Identification of 3-O-methyl-alpha-methyldopamine as a urinary metabolite of 3,4-methylenedioxyamphetamine in dog and monkey.
    Midha KK; Cooper JK; By A; Ethier JC
    Drug Metab Dispos; 1977; 5(2):143-8. PubMed ID: 15806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. alpha-Methyldopamine, a key intermediate in the metabolic disposition of 3,4-methylenedioxyamphetamine in vivo in dog and monkey.
    Midha KK; Hubbard JW; Bailey K; Cooper JK
    Drug Metab Dispos; 1978; 6(6):623-30. PubMed ID: 33023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-O-methyl-alpha-methyldopamine, a urinary metabolite of p-methoxyamphetamine in dog and monkey.
    Hubbard JW; Bailey K; Midha KK; Cooper JK
    Drug Metab Dispos; 1981; 9(3):250-4. PubMed ID: 6113935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic O-demethylation of 3,4-dimethoxyamphetamine in vivo in dog and monkey.
    Midha KK; Bailey K; Cooper JK; Hubbard JW
    Xenobiotica; 1979 Aug; 9(8):485-90. PubMed ID: 117645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolism of p-methoxyamphetamine in dog and monkey. O-demethylation as a major route.
    Hubbard JW; Midha KK; Cooper JK
    Drug Metab Dispos; 1977; 5(4):329-34. PubMed ID: 19212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of ibopamine metabolites in rat and dog urine.
    Kuo GY; Hwang BY; Lynn RK
    Drug Metab Dispos; 1988; 16(6):793-8. PubMed ID: 2907455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of methylenedioxymethamphetamine: formation of dihydroxymethamphetamine and a quinone identified as its glutathione adduct.
    Hiramatsu M; Kumagai Y; Unger SE; Cho AK
    J Pharmacol Exp Ther; 1990 Aug; 254(2):521-7. PubMed ID: 1974641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of methoxyphenamine in man and in monkey.
    Midha KK; Cooper JK; Mcgilveray IJ; Coutts RT; Dawe R
    Drug Metab Dispos; 1976; 4(6):568-76. PubMed ID: 11979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major metabolites of (+/-)3,4-methylenedioxyamphetamine (MDA) do not mediate its toxic effects on brain serotonin neurons.
    McCann UD; Ricaurte GA
    Brain Res; 1991 Apr; 545(1-2):279-82. PubMed ID: 1860050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ibopamine, an orally active dopamine-like drug: metabolism and pharmacokinetics in dogs.
    Pocchiari F; Pataccini R; Castelnovo P; Longo A; Paro M; Casagrande C
    Arzneimittelforschung; 1986 Feb; 36(2A):341-4. PubMed ID: 3707646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatotoxicity of 3,4-methylenedioxyamphetamine and alpha-methyldopamine in isolated rat hepatocytes: formation of glutathione conjugates.
    Carvalho M; Milhazes N; Remião F; Borges F; Fernandes E; Amado F; Monks TJ; Carvalho F; Bastos ML
    Arch Toxicol; 2004 Jan; 78(1):16-24. PubMed ID: 14586543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The comparative metabolism of zolazepam in rat, dog and monkey.
    Baukema J; Okerholm RA; Glazko AJ
    Res Commun Chem Pathol Pharmacol; 1975 Feb; 10(2):227-38. PubMed ID: 808840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicological detection of the designer drug 3,4-methylenedioxyethylamphetamine (MDE, "Eve") and its metabolites in urine by gas chromatography-mass spectrometry and fluorescence polarization immunoassay.
    Ensslin HK; Kovar KA; Maurer HH
    J Chromatogr B Biomed Appl; 1996 Aug; 683(2):189-97. PubMed ID: 8891915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intracerebroventricular administration of 5-(glutathion-S-yl)-alpha-methyldopamine on brain dopamine, serotonin, and norepinephrine concentrations in male Sprague-Dawley rats.
    Miller RT; Lau SS; Monks TJ
    Chem Res Toxicol; 1996 Mar; 9(2):457-65. PubMed ID: 8839050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, in vitro formation, and behavioural effects of glutathione regioisomers of alpha-methyldopamine with relevance to MDA and MDMA (ecstasy).
    Easton N; Fry J; O'Shea E; Watkins A; Kingston S; Marsden CA
    Brain Res; 2003 Oct; 987(2):144-54. PubMed ID: 14499958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of epinine 3-O-sulphate and 4-O-sulphate.
    Ferrini R; Merlo L; Miragoli G
    Arch Int Pharmacodyn Ther; 1987 Sep; 289(1):37-45. PubMed ID: 3435204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereochemical differences in the metabolism of 3,4-methylenedioxymethamphetamine in vivo and in vitro: a pharmacokinetic analysis.
    Cho AK; Hiramatsu M; Distefano EW; Chang AS; Jenden DJ
    Drug Metab Dispos; 1990; 18(5):686-91. PubMed ID: 1981721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of MDMA and its metabolites in urine by GC and GC/MS].
    Shen M; Yan W; Shen B; Xiang P; Huang Z; Liu W; Bo J
    Fa Yi Xue Za Zhi; 1998; 14(1):10-1, 24, 61. PubMed ID: 11360579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of nisoldipine. III. Biotransformation of nisoldipine in rat, dog, monkey, and man.
    Scherling D; Karl W; Ahr G; Ahr HJ; Wehinger E
    Arzneimittelforschung; 1988 Aug; 38(8):1105-10. PubMed ID: 2973788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and chemical properties of ibopamine and of related esters of N-substituted dopamines--synthesis of ibopamine metabolites.
    Casagrande C; Santangelo F; Saini C; Doggi F; Gerli F; Cerri O
    Arzneimittelforschung; 1986 Feb; 36(2A):291-303. PubMed ID: 3707640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.